[Prescription patterns and safety of benzodiazepines in Korea]
Kwon JW, Hwang JS, Oh SH, Kwak SJ, Park EJ, Oh KS, Lee KW, Lee BC, Woo JM
Record ID 32013000524
Korean
Original Title:
벤조다이아제핀 계열 약물의 처방양상 및 안전성
Authors' recommendations:
Overall BZD dosage was lower than the WHO defined daily dose, but BZD prescription was frequent. The average national prescribing prevalence per 100 people per one year was 23.7% for ≥1 day, 7.8% for ≥30 days, 3.2% for ≥180 days. BZD prescription was much more frequent among elderly people (≥ 65 years old) and the one-year prescription trend was similar during the five years of the study period.
The risk for fracture was higher in patients with BZD prescription than in people without BZD prescription. In particular, elderly people who were 65 years old or older and were prescribed long-acting BZD had higher OR than other groups. People with short-term BZD prescription or exposure in the early period from BZD initial prescription had trends of higher risk for fracture than those with long-term use or exposure in the late period.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
https://www.neca.re.kr/lay1/program/S1T11C145/report/view.do?seq=62
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
South Korea
MeSH Terms
- Benzodiazepines
- Drug Prescriptions
- Korea
Contact
Organisation Name:
National Evidence-based healthcare Collaborating Agency
Contact Address:
National Evidence-based Healthcare Collaborating Agency (NECA), 3~5F Health and Welfare Social Administration B/D, 400 Neungdong-ro, Gwangjin-gu, Seoul, Korea.
Contact Name:
int@neca.re.kr
Contact Email:
int@neca.re.kr
Copyright:
National Evidence-based Healthcare Collaborating Agency (NECA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.